| Ansøgningsnr. og dato | 20776430.9 (espacenet) (Federated) (European Patent Register), 20200325 | | Patent/reg.nr. og dato | DK/EP 3811979, 20231129 | | Tilgængelighedsdato | 20210428 | | Prioritetsnr. og dato | CN 201910231203, 20190326 | | EP publ. nr. og dato |
EP 3811979 20210428 | | Løbedag | | | Ansøger/indehaver | RemeGen Co., Ltd., China (Shandong) Pilot Free Trade Zone
Yantai District, Yantai Development Zone
No.58 Beijing Middle Road
Shandong 264006, CN | | Ansøgers ref. nr. | V468766DK00 | | Opfinder | LI, Zhuanglin, No. 58
Beijing Middle Road Economic and Technological
Development Zone Yantai, Shandong 264006, CN,
XU, Qiaoyu, No. 58
Beijing Middle Road Economic and Technological
Development Zone Yantai, Shandong 264006, CN,
YAO, Xuejing, No. 58
Beijing Middle Road Economic and Technological
Development Zone Yantai, Shandong 264006, CN,
BAO, Qianjing, No. 58
Beijing Middle Road Economic and Technological
Development Zone Yantai, Shandong 264006, CN,
FANG, Jianmin, No. 58
Beijing Middle Road Economic and Technological
Development Zone Yantai, Shandong 264006, CN | | Fuldmægtig | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 38/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/20 (2006.01) , A61K 47/65 (2017.01) , A61K 47/68 (2017.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) | | Titel/benævnelse | Farmaceutisk præparat med anti-HER2-antistoflægemiddelkonjugat | | Internationalt ansøgningsnr. | CN2020081138 | | Internationalt publ. nr. | WO2020192693 | | Relateret sag (certifikat) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
